Roivant Sciences (ROIV) Return on Capital Employed Growth (1y) (2022 - 2025)
Roivant Sciences (ROIV) Return on Capital Employed Growth (1y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 472.40 Bn | 467.61 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.23 Bn | 114.98 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn | 2,400.00 |
| 10 | Roivant Sciences | 24.15 Bn | 24.15 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11,785.00 |
| Sep 30, 2025 | -11,073.00 |
| Jun 30, 2025 | -9,439.00 |
| Dec 31, 2024 | -1,448.00 |
| Sep 30, 2024 | 15,868.00 |
| Jun 30, 2024 | 14,509.00 |
| Dec 31, 2023 | 20,166.00 |
| Sep 30, 2023 | 2,558.00 |
| Jun 30, 2023 | 1,848.00 |
| Dec 31, 2022 | -3,902.00 |
| Sep 30, 2022 | -5,645.00 |
| Jun 30, 2022 | -6,785.00 |